Discover how a strategic acquisition in pharma packaging is set to drive growth as the market aims to double by 2028 ...

Novocure's PANOVA-3 trial shows TTFields therapy with chemotherapy improves survival in pancreatic cancer, marking a ...

The Portuguese contract development and manufacturing organization (CDMO) Hovione continues its spray drying expansion with ...

The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...

A conversation with Steve Rosenberg, CEO of uMotif electronic clinical outcome assessment (eCOA) - collecting data ...

We’re thrilled to announce that we have migrated Confectionery News to a new platform. Our expert coverage of the chocolate, ...

The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...

From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has ...

The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.

By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of ...